Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.

<h4>Background</h4>Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian randomization method, the association is likely to be causal if genetic variants that affect CRP level are associated with markers of diabetes development and diabetes. Our...

Full description

Bibliographic Details
Main Authors: Eric J Brunner, Mika Kivimäki, Daniel R Witte, Debbie A Lawlor, George Davey Smith, Jackie A Cooper, Michelle Miller, Gordon D O Lowe, Ann Rumley, Juan P Casas, Tina Shah, Steve E Humphries, Aroon D Hingorani, Michael G Marmot, Nicholas J Timpson, Meena Kumari
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-08-01
Series:PLoS Medicine
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18700811/pdf/?tool=EBI
id doaj-39cef5eb7a05484caf34342a337e04d6
record_format Article
spelling doaj-39cef5eb7a05484caf34342a337e04d62021-08-11T04:31:31ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762008-08-0158e15510.1371/journal.pmed.0050155Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.Eric J BrunnerMika KivimäkiDaniel R WitteDebbie A LawlorGeorge Davey SmithJackie A CooperMichelle MillerGordon D O LoweAnn RumleyJuan P CasasTina ShahSteve E HumphriesAroon D HingoraniMichael G MarmotNicholas J TimpsonMeena Kumari<h4>Background</h4>Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian randomization method, the association is likely to be causal if genetic variants that affect CRP level are associated with markers of diabetes development and diabetes. Our objective was to examine the nature of the association between CRP phenotype and diabetes development using CRP haplotypes as instrumental variables.<h4>Methods and findings</h4>We genotyped three tagging SNPs (CRP + 2302G > A; CRP + 1444T > C; CRP + 4899T > G) in the CRP gene and measured serum CRP in 5,274 men and women at mean ages 49 and 61 y (Whitehall II Study). Homeostasis model assessment-insulin resistance (HOMA-IR) and hemoglobin A1c (HbA1c) were measured at age 61 y. Diabetes was ascertained by glucose tolerance test and self-report. Common major haplotypes were strongly associated with serum CRP levels, but unrelated to obesity, blood pressure, and socioeconomic position, which may confound the association between CRP and diabetes risk. Serum CRP was associated with these potential confounding factors. After adjustment for age and sex, baseline serum CRP was associated with incident diabetes (hazard ratio = 1.39 [95% confidence interval 1.29-1.51], HOMA-IR, and HbA1c, but the associations were considerably attenuated on adjustment for potential confounding factors. In contrast, CRP haplotypes were not associated with HOMA-IR or HbA1c (p = 0.52-0.92). The associations of CRP with HOMA-IR and HbA1c were all null when examined using instrumental variables analysis, with genetic variants as the instrument for serum CRP. Instrumental variables estimates differed from the directly observed associations (p = 0.007-0.11). Pooled analysis of CRP haplotypes and diabetes in Whitehall II and Northwick Park Heart Study II produced null findings (p = 0.25-0.88). Analyses based on the Wellcome Trust Case Control Consortium (1,923 diabetes cases, 2,932 controls) using three SNPs in tight linkage disequilibrium with our tagging SNPs also demonstrated null associations.<h4>Conclusions</h4>Observed associations between serum CRP and insulin resistance, glycemia, and diabetes are likely to be noncausal. Inflammation may play a causal role via upstream effectors rather than the downstream marker CRP.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18700811/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Eric J Brunner
Mika Kivimäki
Daniel R Witte
Debbie A Lawlor
George Davey Smith
Jackie A Cooper
Michelle Miller
Gordon D O Lowe
Ann Rumley
Juan P Casas
Tina Shah
Steve E Humphries
Aroon D Hingorani
Michael G Marmot
Nicholas J Timpson
Meena Kumari
spellingShingle Eric J Brunner
Mika Kivimäki
Daniel R Witte
Debbie A Lawlor
George Davey Smith
Jackie A Cooper
Michelle Miller
Gordon D O Lowe
Ann Rumley
Juan P Casas
Tina Shah
Steve E Humphries
Aroon D Hingorani
Michael G Marmot
Nicholas J Timpson
Meena Kumari
Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.
PLoS Medicine
author_facet Eric J Brunner
Mika Kivimäki
Daniel R Witte
Debbie A Lawlor
George Davey Smith
Jackie A Cooper
Michelle Miller
Gordon D O Lowe
Ann Rumley
Juan P Casas
Tina Shah
Steve E Humphries
Aroon D Hingorani
Michael G Marmot
Nicholas J Timpson
Meena Kumari
author_sort Eric J Brunner
title Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.
title_short Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.
title_full Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.
title_fullStr Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.
title_full_unstemmed Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.
title_sort inflammation, insulin resistance, and diabetes--mendelian randomization using crp haplotypes points upstream.
publisher Public Library of Science (PLoS)
series PLoS Medicine
issn 1549-1277
1549-1676
publishDate 2008-08-01
description <h4>Background</h4>Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian randomization method, the association is likely to be causal if genetic variants that affect CRP level are associated with markers of diabetes development and diabetes. Our objective was to examine the nature of the association between CRP phenotype and diabetes development using CRP haplotypes as instrumental variables.<h4>Methods and findings</h4>We genotyped three tagging SNPs (CRP + 2302G > A; CRP + 1444T > C; CRP + 4899T > G) in the CRP gene and measured serum CRP in 5,274 men and women at mean ages 49 and 61 y (Whitehall II Study). Homeostasis model assessment-insulin resistance (HOMA-IR) and hemoglobin A1c (HbA1c) were measured at age 61 y. Diabetes was ascertained by glucose tolerance test and self-report. Common major haplotypes were strongly associated with serum CRP levels, but unrelated to obesity, blood pressure, and socioeconomic position, which may confound the association between CRP and diabetes risk. Serum CRP was associated with these potential confounding factors. After adjustment for age and sex, baseline serum CRP was associated with incident diabetes (hazard ratio = 1.39 [95% confidence interval 1.29-1.51], HOMA-IR, and HbA1c, but the associations were considerably attenuated on adjustment for potential confounding factors. In contrast, CRP haplotypes were not associated with HOMA-IR or HbA1c (p = 0.52-0.92). The associations of CRP with HOMA-IR and HbA1c were all null when examined using instrumental variables analysis, with genetic variants as the instrument for serum CRP. Instrumental variables estimates differed from the directly observed associations (p = 0.007-0.11). Pooled analysis of CRP haplotypes and diabetes in Whitehall II and Northwick Park Heart Study II produced null findings (p = 0.25-0.88). Analyses based on the Wellcome Trust Case Control Consortium (1,923 diabetes cases, 2,932 controls) using three SNPs in tight linkage disequilibrium with our tagging SNPs also demonstrated null associations.<h4>Conclusions</h4>Observed associations between serum CRP and insulin resistance, glycemia, and diabetes are likely to be noncausal. Inflammation may play a causal role via upstream effectors rather than the downstream marker CRP.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18700811/pdf/?tool=EBI
work_keys_str_mv AT ericjbrunner inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT mikakivimaki inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT danielrwitte inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT debbiealawlor inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT georgedaveysmith inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT jackieacooper inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT michellemiller inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT gordondolowe inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT annrumley inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT juanpcasas inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT tinashah inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT steveehumphries inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT aroondhingorani inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT michaelgmarmot inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT nicholasjtimpson inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
AT meenakumari inflammationinsulinresistanceanddiabetesmendelianrandomizationusingcrphaplotypespointsupstream
_version_ 1721211701061222400